stockportfolio.pro
Stocks / INSM vs VTRS
INSM vs VTRS
Insmed Incorporated and Viatris Inc. side by side — fundamentals from SEC filings, refreshed nightly. Sector: Healthcare.
INSM is the larger company ($20.9B vs $18.3B). On the fundamentals, INSM grows revenue faster (29.8% vs 3.7%); VTRS earns a higher net margin (-24.6% vs -210.5%); VTRS has the stronger return on equity (-23.9% vs -172.8%). Full numbers below — the stronger figure on each row is in green.
| Insmed Incorporated (INSM) | Viatris Inc. (VTRS) | |
|---|---|---|
| Market cap | $20.9B | $18.3B |
| Revenue (latest FY) | $606.42M | $14.30B |
| Net income (latest FY) | $-1.28B | $-3.51B |
| Revenue growth (5y CAGR) | 29.8% | 3.7% |
| Net margin | -210.5% | -24.6% |
| Return on equity | -172.8% | -23.9% |
| P/E ratio | — | — |
| Dividend yield | — | — |
| Profitable years (of last 10) | 0 | 4 |
| Positive free cash flow | No | Yes |
Compare with another company:
See the full INSM vs VTRS breakdown
Both companies across 19 years of income statement, balance sheet and cash flow — with ratios, health checks and Ask, the SEC-grounded research assistant. Free, no account needed.
Open INSM's full financials → Open VTRS's full financials →More comparisons
Frequently asked questions
Which is bigger, INSM or VTRS?
Insmed Incorporated is larger by market capitalization — $20.9B versus $18.3B.
Which grows faster, INSM or VTRS?
Over the last five fiscal years, Insmed Incorporated grew revenue faster — 29.8%/yr versus 3.7%/yr, computed from SEC-filed statements.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.
Keep exploring
INSM fundamentals → · VTRS fundamentals → · All 1,500+ companies → · Free screener →